By Gail Hairston
Derek Young, University of Kentucky College of Arts & Sciences assistant professor of statistics, recently published his new book, “Handbook of Regression Methods,” which concisely covers numerous traditional, contemporary and nonstandard regression methods.
By Gail Hairston
A team of scientists at the University of Kentucky and at the Massachusetts Institute of Technology have been awarded a $200,000 National Science Foundation grant to develop a prototype of a battery utilizing chemical components prepared at UK.
By Dave Melanson
Robby Pace, a chemistry graduate student, working at UK CAER.
The University of Kentucky Center for Applied Energy Research’s (CAER) Biofuels and Environmental Catalysis Group has received a $2 million U.S. Department of Energy (DOE) grant to develop new emissions technology for low-temperature gasoline.
By Vice President for Research Lisa Cassis
Abigail Firey didn’t set out to blaze trails in digital humanities. But that’s exactly what has happened in her quest to get a grasp on the enormous corpus of unpublished manuscripts that are part of her work in medieval canon law.
By Amanda Lee
Fiona Foster. Photo by William Bingham.
A team of scientists at the University of Kentucky and at the Massachusetts Institute of Technology have been awarded a National Science Foundation grant to develop a prototype of a battery utilizing chemical components prepared at UK. Professors Susan Odom and John Anthony (UK Chemistry) synthesized new organic compounds as donors and acceptors for a type of battery called a redox flow battery (RFB), currently of great interest for large-scale energy storage.
Metallo-β-lactamases (MBLs) are Zn(II)-containing enzymes produced by bacteria that inactivate all b-lactam containing antibiotics, including the carbapenems, which are antibiotics of last resort. While the MBLs have been studied for over 50 years, there are no clinical inhibitors for these enzymes. Therefore, there are few antibiotics available to treat bacterial infections caused by bacteria that produce a MBL. To address this problem, a multi-institution team of synthetic organic chemists (UC San Diego), medicinal chemists (UT Austin), microbiologists and MD’s (Case Western and the Cleveland VA), and structural biologists/biochemists (Miami University) teamed together to identify and develop new potential leads. In the seminar, recent results on a new inhibitor scaffold will be presented, along with biophysical studies on several other recently reported compounds in the literature.
